TY - JOUR
T1 - Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer
T2 - A multicenter cohort study
AU - Latenstein, Anouk E. J.
AU - Dijksterhuis, Willemieke P. M.
AU - Mackay, Tara M.
AU - Beijer, Sandra
AU - van Eijck, Casper H. J.
AU - de Hingh, Ignace H. J. T.
AU - Molenaar, I. Quintus
AU - van Oijen, Martijn G. H.
AU - van Santvoort, Hjalmar C.
AU - de van der Schueren, Marian A. E.
AU - de Vos-Geelen, Judith
AU - de Vries, Jeanne H. M.
AU - Wilmink, Johanna W.
AU - Besselink, Marc G.
AU - van Laarhoven, Hanneke W. M.
AU - Dutch Pancreatic Canc Grp
N1 - Funding Information:
The Dutch Pancreatic Cancer Project, including the Netherlands Cancer Registry, was support by the Dutch Cancer Society (KWF Kankerbestrijding; grant no. UVA2013-5842). The authors thank the registration team of the Netherlands Cancer Registry for their dedicated data collection.
Funding Information:
AL has received research funding from Mylan and Allergan. MvO has received unrestricted research grants from BMS, Merck Serono, Nordic, Roche, and Servier. JdV has received non‐financial support and institutional research funding from Servier, outside the submitted work. HvL has served as a consultant for BMS, Celgene, Lilly, Nordic, and Servier, and has received unrestricted research funding from Bayer, BMS, Celgene, Lilly, Merck Serono, MSD, Nordic, Philips, Roche, and Servier. IdH has received an unrestricted research fund paid to the institute from QPS/RanD, ROCHE, and KWF for unrelated research. The other authors have nothing to disclose.
Publisher Copyright:
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2020/12
Y1 - 2020/12
N2 - It is unclear to what extent patients with pancreatic cancer have cachexia and had a dietetic consult for nutritional support. The aim was to assess the prevalence of cachexia, dietitian consultation, and overall survival in these patients. This prospective multicenter cohort study included patients with pancreatic cancer, who participated in the Dutch Pancreatic Cancer Project and completed patient reported outcome measures (2015-2018). Additional data were obtained from the Netherlands Cancer Registry. Cachexia was defined as self-reported >5% body weight loss, or >2% in patients with a BMI
AB - It is unclear to what extent patients with pancreatic cancer have cachexia and had a dietetic consult for nutritional support. The aim was to assess the prevalence of cachexia, dietitian consultation, and overall survival in these patients. This prospective multicenter cohort study included patients with pancreatic cancer, who participated in the Dutch Pancreatic Cancer Project and completed patient reported outcome measures (2015-2018). Additional data were obtained from the Netherlands Cancer Registry. Cachexia was defined as self-reported >5% body weight loss, or >2% in patients with a BMI
KW - QUALITY-OF-LIFE
KW - NUTRITIONAL SUPPORT
KW - CLINICAL NUTRITION
KW - SURGERY
KW - GUIDELINES
KW - DIAGNOSIS
KW - CRITERIA
KW - MASS
KW - AGE
U2 - 10.1002/cam4.3556
DO - 10.1002/cam4.3556
M3 - Article
C2 - 33107709
SN - 2045-7634
VL - 9
SP - 9385
EP - 9395
JO - Cancer Medicine
JF - Cancer Medicine
IS - 24
ER -